[HLA-A*1101 & B2M & KRASG12C (VVVGACGVGK)

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co LtdAsthma
Details
9MW38119MW3811Phase 1 ClinicalMabwell (Shanghai) Bioscience Co LtdSolid tumours; Idiopathic Pulmonary Fibrosis; Neoplasms; Fibrosis; Pulmonary Fibrosis
Details
LASN-03Lassen Therapeutics
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )ApprovedThrombocytopenia
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호